CHELSEA POE: Open Payments
NPI 1538628656 · ASHEBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 12 payments from 7 companies in 2025. Trend: 2023 $570 · 2024 $595 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Novo Nordisk Inc | 2 | $39 |
| Lilly USA, LLC | 1 | $29 |
| PFIZER INC. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, Wegovy, MOUNJARO, AIRSUPRA, FARXIGA, NURTEC ODT, CONTRAVE.
Industry payments across NC — which companies pay providers there.
